中医升降理论在脾胃病临床中的应用

Clinical application of TCM Shengjiang theory in treating PWiwei diseases

目的:探讨中医升降理论在脾胃病临床中的应用。方法:随机选取2016年7月-2018年7月我院收治的脾胃病患者60例,采用SPSS21.0将入组患者按先后序列号(1~60)随机平均分为常规西药治疗组(30例)与中医升降理论组(30例),常规西药治疗组患者接受常规西药治疗,中医升降理论组患者接受中医升降理论指导治疗,然后统计分析两组患者的临床疗效、不良反应发生情况及复发情况。结果:中医升降理论组患者治疗的总有效率为96.7%(29/30),显著高于常规西药治疗组的80.0%(P<0.05),中医证候积分、镜下溃疡评分均显著降低(P<0.05),C反应蛋白(C-Reactive Protein,CRP)、红细胞沉降率(Erythrocyte Sedimentation Rate,ESR)、红细胞分布宽度(Red Cellvolume Distribution Width,RDW)、血小板计数(Blood Platelet,PLT)水平均显著降低(P<0.05),幽门螺杆菌(Helicobacterpylori,Hp)根除率(96.7%)显著高于常规西药治疗组的63.3%(P<0.05),不良反应发生率、复发率均显著低于常规西药治疗组的16.7%、13.3%(P<0.05)。结论:中医升降理论在脾胃病临床中的应用效果较常规西药治疗好,值得在临床推广。

Objective:To investigate clinical application of TCM Shengjiang theory (升降理论) in treating Piwei diseases. Methods:60 cases were divided into 2 groups,30 cases in each.The conventional group was given the conventional western medicine treatment;and the TCM group was given TCM therapy based on TCM Shengjiang theory.Results:The total efficiency in the TCM group was 96.7%,which was significantly higher than 80% in the conventional group (P<0.05).In the TCM group,TCM syndrome scores and microscopic ulcer scores were significantly lower (P<0.05);CRP,ESR,RDW,PLT levels were significantly lower (P<0.05);Hp eradication rate was 96.7%,significantly higher than 63.3% in the conventional group (P<0.05);the incidence of adverse reactions,recurrence rate were significantly lower than 16.7%, 13.3% in the conventional group (P<0.05).Conclusion:TCM Shengjiang theory on Piwei diseases shows a good effect,and is worthy of promotion.